Heparan Sulfate Differentially Regulates Fibroblast Binding by Extracellular Vesicles and Human Cytomegalovirus
Journal of Extracellular Vesicles · 2026-11 · 15 (11)
DOI: 10.1002/jev2.70390 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Extracellular Vesicles, online erschienen am 03.11.2026. Verfasst von Vladimir Bokun und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Reproductive and Developmental Biology, Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College Lond…. Hauptthemen laut MEDLINE: Heparan Sulfate, Cytomegalovirus, Extracellular Vesicles, Fibroblasts. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: March of Dimes Prematurity Research Centre grant, NIAID NIH HHS, NIH HHS.
Abstract (Originalsprache)
Extracellular vesicles (EVs) are lipid‐enclosed particles produced by cells as a vehicle of intercellular communication and cargo exchange. Virus‐infected cells produce EVs with altered cargo, which can include viral components. These EVs play functional roles in multiple aspects of viral infection. Their interactions with cells, including those occurring at the cellular surface prior to internalization, which are key to their subsequent functional effects, have not been studied extensively. In this work, we investigate the role of cellular glycosaminoglycans (GAGs)—major constituents of the extracellular matrix (ECM)—in cell binding by EVs produced by homeostatic cells and those infected with human cytomegalovirus (HCMV). We show that EVs from both HCMV‐infected and uninfected cells interact with heparin, a highly sulfated form of heparan sulfate. However, in the context of binding to fibroblast cells, we show that heparan sulfate on both the cell and the EV surface inhibits EV‐cell interactions, while promoting attachment by human cytomegalovirus. Instead of GAGs, EVs were found to interact with other ECM constituents, namely collagen and fibronectin, on the fibroblast surface. This work shows that heparan sulfate serves as a bi‐directional negative regulator of fibroblast binding by EVs, while acting as a positive regulator of HCMV attachment. Thus, EVs and HCMV appear to utilize distinct, non‐overlapping ECM ligands for cell binding, in both homeostasis and during HCMV infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Reproductive and Developmental Biology, Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, London, UK.
ORCID-Profile: Vladimir Bokun, Antonio Di Maio, Wengang Chai, Beth Holder, Yan Liu
Förderung
- March of Dimes Prematurity Research Centre grant
- NIAID NIH HHS
- NIH HHS
- Wellcome Trust Multi-User Equipment
- National Institute of Allergy and Infectious Diseases
- Wellcome Trust Biomedical Resource
- National Institutes of Health
Zitieren
APA
Bokun, V., Di Maio, A., Zhang, Y., Chai, W., Holder, B., & Liu, Y. (2026). Heparan Sulfate Differentially Regulates Fibroblast Binding by Extracellular Vesicles and Human Cytomegalovirus. Journal of Extracellular Vesicles, 15(11). https://doi.org/10.1002/jev2.70390
Vancouver
Bokun V, Di Maio A, Zhang Y, Chai W, Holder B, Liu Y. Heparan Sulfate Differentially Regulates Fibroblast Binding by Extracellular Vesicles and Human Cytomegalovirus. Journal of Extracellular Vesicles. 2026;15(11). doi:10.1002/jev2.70390
BibTeX
@article{Bokun2026,
author = {Bokun, Vladimir and Di Maio, Antonio and Zhang, Yibing and Chai, Wengang and Holder, Beth and Liu, Yan},
title = {Heparan Sulfate Differentially Regulates Fibroblast Binding by Extracellular Vesicles and Human Cytomegalovirus},
journal = {Journal of Extracellular Vesicles},
year = {2026},
volume = {15},
number = {11},
doi = {10.1002/jev2.70390}
}
EUVIMED